Kaixin F. Liu
Changhongjie, 300071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clinical practice of preoperative interventional embolization combined with robotic surgery in the treatment of adrenal pheochromocytoma
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: July 21, 2026
Effects and mechanism of carrier-free self-assembled nanoparticles of natural products in attenuating pulmonary edema.
Journal: Journal of nanobiotechnology
Published: December 31, 2025
Fuzheng Jiedu formula attenuates acute pneumonia by coordinated regulation of macrophage NLRP3 inflammasome and neutrophil NETs.
Journal: Chinese medicine
Published: September 25, 2025
Self-Assembled Baicalein-Resveratrol Nanomedicine Synergistically Modulates Multiple Pathways to Alleviate Pathogen-Induced Pneumonia.
Journal: Phytotherapy research : PTR
Published: June 27, 2025
Classification of pulmonary inflammation stages and assessment of multicomponent drug intervention based on spatiotemporal imaging variations utilizing RhB-conjugated poly-L-lysine nanoparticles.
Journal: Journal of pharmaceutical analysis
Published: June 11, 2025
Kunxinning granules alleviate perimenopausal syndrome by supplementing estrogen deficiency.
Journal: Frontiers in pharmacology
Published: January 02, 2025
Baicalein disrupts the KEAP1-NRF2 interaction to alleviate oxidative stress injury by inhibiting M1 macrophage polarization.
Journal: Free radical biology & medicine
Published: September 14, 2024
Ginsenoside CK targets PHD2 to prevent platelet adhesion and enhance blood circulation by modifying the three-dimensional arrangement of collagen.
Journal: Acta pharmaceutica Sinica. B
Published: July 10, 2024
Ginsenoside CK targeting KEAP1-DGR/Kelch domain disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: May 07, 2023
Astragaloside IV protects against lung injury and pulmonary fibrosis in COPD by targeting GTP-GDP domain of RAS and downregulating the RAS/RAF/FoxO signaling pathway.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: April 19, 2023
Astragaloside IV targets PRDX6, inhibits the activation of RAC subunit in NADPH oxidase 2 for oxidative damage.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: February 01, 2023
Ursolic acid inhibits the cholesterol biosynthesis and alleviates high fat diet-induced hypercholesterolemia via irreversible inhibition of HMGCS1 in vivo.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: January 04, 2022
Last Updated: 09/26/2026